Oric Pharmaceuticals

Developer of small-molecule drugs for the treatment of cancers

placeSan Francisco, California, United States calendar_todayFounded 2014 groups86 employees language oricpharma.com

Registered entities

Social engagement

Social engagement: 11.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

36 investors on record; lead investors include Trinitas Capital Management, Taiho Ventures, Fidelity Investments, The Column Group; 2 have since exited.

Investor typeCountShare
Venture capital2056%
Private equity514%
Other / undisclosed1131%

Hiring activity

Hires periodically

9 roles tracked across 5 of the last 12 months

6 Jun 2026 · Director, Medical Affairs · South San Francisco

13 Apr 2026 · Director, Rinzimetostat CMC Development Team Leader · South San Francisco

9 Mar 2026 · Senior Vice President/Vice President, Regulatory Affairs · San Diego

13 Jan 2026 · Director Information Technology, Development Operations · San Diego

19 Nov 2025 · Director, CMC Regulatory Affairs · South San Francisco

Based on job postings tracked across public sources.

Recent activity

8 Jun 2026
Event
Goldman Sachs 47th Annual Global Healthcare Conference
2 Jun 2026
Event
Jefferies Global Healthcare Conference fireside chat
21 Apr 2026
Event
AACR2026
Coming soon